Company intelligence / Profile preview

CareCeutics

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

CareCeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for oncology supportive care and other underserved medical needs. The company's lead program, CC-01, is a small molecule currently in Phase 2 clinical trials for the prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN), a common and debilitating side effect of cancer treatment. CareCeutics aims to address significant unmet needs in the oncology space by improving patient outcomes and quality of life during and after treatment. Headquartered in New York, the company is led by an experienced management team with a track record in drug development and commercialization.

Therapeutic areas: OncologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on CareCeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CareCeutics.

Explore the full profile